Results 211 to 220 of about 38,200 (304)

Systemic Inflammation and Subclinical Hepatic Synthetic Dysfunction Following Doxorubicin‐Cyclophosphamide Chemotherapy in Ethiopian Women With Breast Cancer: A Prospective Cohort Study

open access: yesHealth Science Reports, Volume 9, Issue 9, September 2026.
ABSTRACT Background and Aims Doxorubicin‐cyclophosphamide (AC) chemotherapy induces hepatotoxicity through oxidative stress and inflammatory pathway activation, but prospective African data are lacking and conventional liver tests may miss subclinical injury.
Tamrat Nida, Abdisa Tufa Bedada
wiley   +1 more source

Genetic Variants at the NAT2 and HLA‐DOA are Associated With Anti‐Tuberculosis Drug‐Induced Liver Injury Susceptibility and Clinical Manifestations in Western Chinese Populations

open access: yesImmunity, Inflammation and Disease, Volume 14, Issue 9, September 2026.
ABSTRACT Background Anti‐tuberculosis drug‐induced liver injury (ATDILI) is one of the most prevalent and serious adverse reactions during anti‐tuberculosis treatment and can potentially lead to liver failure or mortality. This study aims to investigate whether genetic variants in the N‐acetyltransferase 2 gene (NAT2) and the HLA‐DOA gene (HLA‐DOA) are
Zhenzhen Zhao   +6 more
wiley   +1 more source

Roadmap for Mental Health Treatment Utilizing Pharmacogenomic Testing: Case Report

open access: yes
Clinical Case Reports, Volume 14, Issue 9, September 2026.
Allison P. Swanson   +2 more
wiley   +1 more source

Clinician Perspectives on Prescribing Restrictions and Opioid Pain Management in Australian Podiatric Practice: A Qualitative Study

open access: yesJournal of Foot and Ankle Research, Volume 19, Issue 3, September 2026.
ABSTRACT Background Australian‐endorsed general podiatrists and podiatric surgeons (EGPs and EPSs, respectively) operate under a fixed prescribing formulary, the National Podiatry Scheduled Medicines List (NPSML), that restricts access to opioid analgesics including tramadol and tapentadol, despite emerging evidence questioning the efficacy of ...
Lachlan Aquilina   +4 more
wiley   +1 more source

Pharmacogenomics and Epigenetic Regulation Transforming Pediatric Precision Therapeutics. [PDF]

open access: yesJ Pers Med
Satyam SM   +9 more
europepmc   +1 more source

Digital and Biomarker‐Based Monitoring for Schizophrenia‐Treatment Adherence

open access: yesNeuropsychopharmacology Reports, Volume 46, Issue 3, September 2026.
Monitoring technologies integrated with artificial intelligence can enable personalized care, improved adherence, and reduced relapses among psychotic patients. ABSTRACT Background Nonadherence to antipsychotics affects nearly half of patients with schizophrenia, leading to rehospitalization, suicidality, and reduced quality of life.
Samuel Inshutiyimana   +5 more
wiley   +1 more source

The Veterans Aging Cohort Study (VACS)‐National: A Real‐World Data Source Profile

open access: yesPharmacoepidemiology and Drug Safety, Volume 35, Issue 9, September 2026.
ABSTRACT The Veterans Aging Cohort Study (VACS)‐National is a large, longitudinal real‐world data resource derived from electronic health records within the Department of Veterans Affairs (VA), the largest integrated healthcare system in the United States. As of December 2025, VACS‐National includes > 14.9 million Veterans who have received care in the
Christopher T. Rentsch   +13 more
wiley   +1 more source

Home - About - Disclaimer - Privacy